Avadel Pharmaceuticals (AVDL) Gross Margin (2016 - 2020)
Historic Gross Margin for Avadel Pharmaceuticals (AVDL) over the last 12 years, with Q2 2020 value amounting to 67.45%.
- Avadel Pharmaceuticals' Gross Margin fell 119200.0% to 67.45% in Q2 2020 from the same period last year, while for Mar 2021 it was 67.45%, marking a year-over-year decrease of 119900.0%. This contributed to the annual value of 74.29% for FY2020, which is 52300.0% down from last year.
- Avadel Pharmaceuticals' Gross Margin amounted to 67.45% in Q2 2020, which was down 119200.0% from 79.93% recorded in Q1 2020.
- Avadel Pharmaceuticals' Gross Margin's 5-year high stood at 93.99% during Q4 2016, with a 5-year trough of 67.45% in Q2 2020.
- Over the past 5 years, Avadel Pharmaceuticals' median Gross Margin value was 86.12% (recorded in 2018), while the average stood at 84.61%.
- In the last 5 years, Avadel Pharmaceuticals' Gross Margin soared by 18042100bps in 2016 and then plummeted by -123700bps in 2018.
- Avadel Pharmaceuticals' Gross Margin (Quarter) stood at 93.99% in 2016, then decreased by -6bps to 88.35% in 2017, then decreased by -10bps to 79.48% in 2018, then dropped by -2bps to 78.04% in 2019, then fell by -14bps to 67.45% in 2020.
- Its Gross Margin was 67.45% in Q2 2020, compared to 79.93% in Q1 2020 and 78.04% in Q4 2019.